144 related articles for article (PubMed ID: 34127808)
21. Quality of the hematopoietic stem cell graft affects the clinical outcome of allogeneic stem cell transplantation.
Watz E; Remberger M; Ringden O; Ljungman P; Sundin M; Mattsson J; Uhlin M
Transfusion; 2015 Oct; 55(10):2339-50. PubMed ID: 25968813
[TBL] [Abstract][Full Text] [Related]
22. Neither COVID-19, nor cryopreservation, prevented allogeneic product infusion: A report from the National Marrow Donor Program.
Farhadfar N; Newman J; Novakovich J; Barten J; Ndifon ET; Oakes J; Cody M; Pham HP; Auletta JJ; Miller JP; Devine SM; Stefanski HE
Front Immunol; 2022; 13():937900. PubMed ID: 36203566
[TBL] [Abstract][Full Text] [Related]
23. Non-cryopreserved peripheral blood stem cells as a safe and effective alternative for autologous transplantation in multiple myeloma.
Araújo AB; Soares TB; Schmalfuss T; Angeli MH; Furlan JM; Salton GD; Burin MM; Röhsig LM
Transfusion; 2022 Oct; 62(10):1967-1972. PubMed ID: 36052689
[TBL] [Abstract][Full Text] [Related]
24. Cryopreservation of allogeneic PBSC from related and unrelated donors is associated with delayed platelet engraftment but has no impact on survival.
Medd P; Nagra S; Hollyman D; Craddock C; Malladi R
Bone Marrow Transplant; 2013 Feb; 48(2):243-8. PubMed ID: 22732701
[TBL] [Abstract][Full Text] [Related]
25. Coronavirus disease 2019 pandemic and allogeneic hematopoietic stem cell transplantation: a single center reappraisal.
Valentini CG; Chiusolo P; Bianchi M; Metafuni E; Orlando N; Giammarco S; Bacigalupo A; Sica S; Teofili L
Cytotherapy; 2021 Jul; 23(7):635-640. PubMed ID: 33423867
[TBL] [Abstract][Full Text] [Related]
26. Haploidentical T Cell-Replete Transplantation with Post-Transplantation Cyclophosphamide for Patients in or above the Sixth Decade of Age Compared with Allogeneic Hematopoietic Stem Cell Transplantation from an Human Leukocyte Antigen-Matched Related or Unrelated Donor.
Blaise D; Fürst S; Crocchiolo R; El-Cheikh J; Granata A; Harbi S; Bouabdallah R; Devillier R; Bramanti S; Lemarie C; Picard C; Chabannon C; Weiller PJ; Faucher C; Mohty B; Vey N; Castagna L
Biol Blood Marrow Transplant; 2016 Jan; 22(1):119-24. PubMed ID: 26341397
[TBL] [Abstract][Full Text] [Related]
27. [Haploidentical donor peripheral blood stem cell transplantation using third-party cord blood compared with matched unrelated donor transplantation for patients with hematologic malignancies].
Ma X; Chen Y; Liu Y; Cheng TT; Chen X; Zeng C; Hua J; Wang SY; Xu YJ
Zhonghua Xue Ye Xue Za Zhi; 2024 Feb; 45(2):141-147. PubMed ID: 38604790
[No Abstract] [Full Text] [Related]
28. Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia.
Eapen M; Zhang MJ; Tang XY; Lee SJ; Fei MW; Wang HL; Hebert KM; Arora M; Chhabra S; Devine SM; Hamadani M; D'Souza A; Pasquini MC; Phelan R; Rizzo JD; Saber W; Shaw BE; Weisdorf DJ; Horowitz MM
Biol Blood Marrow Transplant; 2020 Jul; 26(7):e161-e166. PubMed ID: 32389803
[TBL] [Abstract][Full Text] [Related]
29. CD3
Ramanathan S; Lum SH; Nademi Z; Carruthers K; Watson H; Flood T; Owens S; Williams E; Hambleton S; Gennery AR; Slatter M
Transplant Cell Ther; 2023 Aug; 29(8):513.e1-513.e9. PubMed ID: 37279857
[TBL] [Abstract][Full Text] [Related]
30. Fresh vs. frozen allogeneic peripheral blood stem cell grafts: A successful timely option.
Alotaibi AS; Prem S; Chen S; Lipton JH; Kim DD; Viswabandya A; Kumar R; Lam W; Law AD; Mattsson J; Michelis FV
Am J Hematol; 2021 Feb; 96(2):179-187. PubMed ID: 33108034
[TBL] [Abstract][Full Text] [Related]
31. Impact of Covid 19 pandemic on hematopoietic stem cell transplantation activities: Report from a single center.
Giammarco S; Sica S; Metafuni E; Limongiello MA; Valentini CG; Sorà F; Marra JD; Bacigalupo A; Teofili L; Chiusolo P
Transfus Apher Sci; 2023 Aug; 62(4):103708. PubMed ID: 37003931
[TBL] [Abstract][Full Text] [Related]
32. Good Engraftment but Quality and Donor Concerns for Cryopreserved Hemopoietic Progenitor Cell Products Collected During the COVID-19 Pandemic.
Purtill D; Hutchins C; Kennedy G; McClean A; Fraser C; Shaw PJ; Chiappini P; Tao H; Ma DD; Kabani K; Bai L; Greenwood M; Bajel A; O'Flaherty E; Curtis DJ; Purins L; Perera T; Tan S; Butler A; Micklethwaite K; Antonenas V; Gottlieb D; Hamad N
Transplant Cell Ther; 2021 Dec; 27(12):1022.e1-1022.e6. PubMed ID: 34571211
[TBL] [Abstract][Full Text] [Related]
33. [Impact of SARS-CoV-2 infection on graft composition and early transplant outcomes following allogeneic hematopoietic stem cell transplantation].
Lin F; Sun H; Chen Y; Zhang YY; Liu J; He Y; Zheng FM; Xu ZL; Wang FR; Kong J; Wang ZD; Wan YY; Mo XD; Wang Y; Cheng YF; Zhang XH; Huang XJ; Xu LP
Zhonghua Xue Ye Xue Za Zhi; 2023 Nov; 44(11):890-899. PubMed ID: 38185517
[No Abstract] [Full Text] [Related]
34. Alemtuzumab, Dual Graft-versus-Host Disease Prophylaxis, and Lower CD3
Lum SH; James B; Ottaviano G; Ewins AM; Patrick K; Ali S; Carpenter B; Silva J; Tewari S; Furness C; Thomas A; Shenton G; Bonney D; Moppett J; Hambleton S; Gennery AR; Amrolia P; Gibson B; Hough R; Rao K; Slatter M; Wynn R
Transplant Cell Ther; 2024 Mar; 30(3):314.e1-314.e12. PubMed ID: 38103787
[TBL] [Abstract][Full Text] [Related]
35. CD34+ Stem Cell Selection and CD3+ T Cell Add-Back from Matched Unrelated Adult Donors in Children with Primary Immunodeficiencies and Hematological Diseases.
Porta F; Comini M; Soncini E; Carracchia G; Maffeis M; Pintabona V; Bolda F; Beghin A; Schumacher RF; Lanfranchi A
Transplant Cell Ther; 2021 May; 27(5):426.e1-426.e9. PubMed ID: 33965183
[TBL] [Abstract][Full Text] [Related]
36. HLA-Matched Sibling versus Unrelated versus Haploidentical Related Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 60 Years with Acute Myeloid Leukemia: A Single-Center Donor Comparison.
Devillier R; Legrand F; Rey J; Castagna L; Fürst S; Granata A; Charbonnier A; Harbi S; d'Incan E; Pagliardini T; Faucher C; Lemarie C; Saillard C; Calmels B; Mohty B; Maisano V; Weiller PJ; Chabannon C; Vey N; Blaise D
Biol Blood Marrow Transplant; 2018 Jul; 24(7):1449-1454. PubMed ID: 29448057
[TBL] [Abstract][Full Text] [Related]
37. [The impact of donor-to-recipient gender compatibility on outcomes of haploid hematopoietic stem cell transplantation in patients with hematological malignancies].
Hu SS; Wu YB; Zhu PP; Shi JM; Yu J; Zhao YM; Lai XY; Liu LZ; Fu HR; Huang H; Luo Y
Zhonghua Xue Ye Xue Za Zhi; 2022 Dec; 43(12):992-1002. PubMed ID: 36709104
[No Abstract] [Full Text] [Related]
38. Haploidentical Transplantation with Post-Transplant Cyclophosphamide versus Unrelated Donor Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
Arcuri LJ; Aguiar MTM; Ribeiro AAF; Pacheco AGF
Biol Blood Marrow Transplant; 2019 Dec; 25(12):2422-2430. PubMed ID: 31386903
[TBL] [Abstract][Full Text] [Related]
39. Comparable outcomes of allogeneic peripheral blood versus bone marrow hematopoietic stem cell transplantation from a sibling donor for pediatric patients.
Kim BK; Hong KT; Choi JY; Kim H; Park HJ; Kang HJ
Ann Hematol; 2024 Jun; 103(6):2051-2058. PubMed ID: 38594416
[TBL] [Abstract][Full Text] [Related]
40. Peripheral Blood or Bone Marrow Stem Cells? Practical Considerations in Hematopoietic Stem Cell Transplantation.
Amouzegar A; Dey BR; Spitzer TR
Transfus Med Rev; 2019 Jan; 33(1):43-50. PubMed ID: 30528986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
